Clinical Trials

Showing trials with last updates posted in 2026.

NCT06208150 | ACTIVE_NOT_RECRUITING | PHASE3
838 participants
NCT06152809 | RECRUITING | PHASE1
10 participants

CIML NK Cells With Venetoclax for AML

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-28
Start Date:
2024-02-20
Completion:
2026-11-30
Conditions
  • Acute Myeloid Leukemia
  • Acute Myeloid Leukemia Recurrent
  • Leukemia
  • Leukemia, Myeloid
Interventions
  • BIOLOGICAL
  • DRUG
No Results Yet
NCT06120283 | RECRUITING | PHASE1
433 participants

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-28
Start Date:
2023-12-01
Completion:
2029-12-31
Conditions
  • Advanced Solid Tumor
  • Advanced Breast Cancer
  • Metastatic Breast Cancer
  • Hormone-receptor-positive Breast Cancer
  • Hormone Receptor Positive Breast Carcinoma
  • Hormone Receptor Positive Malignant Neoplasm of Breast
  • HER2-negative Breast Cancer
  • Hormone Receptor Positive HER-2 Negative Breast Cancer
Interventions
  • DRUG
No Results Yet
NCT05987241 | RECRUITING | PHASE2/PHASE3
992 participants

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-28
Start Date:
2024-02-02
Completion:
2030-09-02
Conditions
  • Muscle Invasive Bladder Urothelial Carcinoma
  • Muscle Invasive Renal Pelvis Urothelial Carcinoma
  • Muscle Invasive Ureter Urothelial Carcinoma
  • Muscle Invasive Urethral Urothelial Carcinoma
  • Stage II Bladder Urothelial Carcinoma AJCC v6 and v7
  • Stage III Bladder Urothelial Carcinoma AJCC v6 and v7
  • Stage IV Bladder Urothelial Carcinoma AJCC v7
Interventions
  • PROCEDURE
  • OTHER
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page